Publications in collaboration with researchers from Universitat de Barcelona (37)

2023

  1. GWAS Meta-Analysis of Suicide Attempt: Identification of 12 Genome-Wide Significant Loci and Implication of Genetic Risks for Specific Health Factors

    American Journal of Psychiatry

2022

  1. Completed suicide is associated with a higher polygenic burden for psychiatric disorders

    European Archives of Psychiatry and Clinical Neuroscience

  2. Mapping genomic loci implicates genes and synaptic biology in schizophrenia

    Nature, Vol. 604, Núm. 7906, pp. 502-508

  3. Toxoplasma gondii Seropositivity Interacts with Catechol-O-methyltransferase Val105/158Met Variation Increasing the Risk of Schizophrenia

    Genes, Vol. 13, Núm. 6

2019

  1. A pharmacogenetic intervention for the improvement of the safety profile of antipsychotic treatments

    Translational Psychiatry, Vol. 9, Núm. 1

2014

  1. Replication of previous genome-wide association studies of psychiatric diseases in a large schizophrenia case-control sample from Spain

    Schizophrenia Research, Vol. 159, Núm. 1, pp. 107-113

2007

  1. Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment

    Journal of Affective Disorders, Vol. 104, Núm. 1-3, pp. 83-90

  2. Identification of two risk haplotypes for schizophrenia and bipolar disorder in the synaptic vesicle monoamine transporter gene (SVMT)

    American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, Vol. 144, Núm. 4, pp. 502-507

2005

  1. Evidence for a combined genetic effect of the 5-HT1A receptor and serotonin transporter genes in the clinical outcome of major depressive patients treated with citalopram

    Journal of Psychopharmacology, Vol. 19, Núm. 2, pp. 166-172

2004

  1. Association analysis between a functional polymorphism in the monoamine oxidase A gene promoter and severe mood disorders

    Psychiatric Genetics, Vol. 14, Núm. 4, pp. 203-208

  2. Dermatoglyphic profile in 22q Deletion syndrome

    American Journal of Medical Genetics - Neuropsychiatric Genetics, Vol. 128 B, Núm. 1, pp. 46-49

  3. Interleukin-1 cluster is associated with genetic risk for schizophrenia and bipolar disorder

    Journal of Medical Genetics, Vol. 41, Núm. 3, pp. 219-223

2003

  1. 5-HTTLPR Polymorphism of the Serotonin Transporter Gene Predicts Non-Remission in Major Depression Patients Treated with Citalopram in a 12-Weeks Follow Up Study

    Journal of Clinical Psychopharmacology, Vol. 23, Núm. 6, pp. 563-567

2002

  1. Analysis of structural polymorphisms and C-1018G promoter variant of the 5-HT1A receptor gene as putative risk factors in major depression [3]

    Molecular Psychiatry

  2. Novel mutations in 5-HT3A and 5-HT3B receptor genes not associated with clozapine response

    Schizophrenia Research, Vol. 58, Núm. 1, pp. 93-97

2001

  1. Association study between novel promoter variants at the 5-HT2C receptor gene and human patients with bipolar affective disorder

    Neuroscience Letters, Vol. 309, Núm. 2, pp. 135-137

  2. Dermatoglyphics and abnormal palmar flexion creases as markers of early prenatal stress in children with idiopathic intellectual disability

    Journal of Intellectual Disability Research, Vol. 45, Núm. 5, pp. 416-423

  3. Genetic variation in the 5-HT5A receptor gene in patients with bipolar disorder and major depression

    Neuroscience Letters, Vol. 303, Núm. 2, pp. 111-114

  4. The 5-HT2A receptor gene 102T/C polymorphism is associated with suicidal behavior in depressed patients

    American Journal of Medical Genetics - Neuropsychiatric Genetics, Vol. 105, Núm. 8, pp. 801-804

  5. Variability in the 5-HT2A receptor gene is associated with seasonal pattern in major depression

    Molecular Psychiatry, Vol. 6, Núm. 2, pp. 239-242